Product Images Rabeprazole Sodium

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 6 images provide visual information about the product associated with Rabeprazole Sodium NDC 51407-184 by Golden State Medical Supply, Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

51407 184 05LB

51407 184 05LB

This is a description of a medication product manufactured by GSMS Incorporated. The product mentioned is a delayed-release tablet called Rabeprazole that contains 20mg of rabeprazole sodium, and is available in a pack of 500 tablets. The package insert provides dosage information, and the product must be stored at a temperature between 15°C-30°C (59°F-86°F) with excursions (brief storage at temporary temperatures) permitted. The medication needs to be protected from moisture and dispensed in tight containers. A medication guide needs to be provided with each patient, and the product must be kept out of reach of children. The product is packaged by GSMS Incorporated located in Camarillo, CA, but manufactured by Lannett Company Inc. located in Seymour, IN.*

Figure 1 - rabeprazole sodium delayed release tablets 1

Figure 1 - rabeprazole sodium delayed release tablets 1

Figure 2 - rabeprazole sodium delayed release tablets 2

Figure 2 - rabeprazole sodium delayed release tablets 2

This text presents data from a study evaluating the efficacy of a drug called RAB, at two different doses (10mg and 20mg), compared to a placebo, in a sample of 68 individuals. The data is presented over a period of 21 days, with heartburn scores ranging from zero (no heartburn) to four (very severe heartburn).*

Figure 3 - rabeprazole sodium delayed release tablets 3

Figure 3 - rabeprazole sodium delayed release tablets 3

This appears to be a tabular format with data on two drugs - Placebo and RAB in two different dosages (10mg and 20mg). The number of participants receiving each of these treatments is also provided.*

Figure 4 - rabeprazole sodium delayed release tablets 4

Figure 4 - rabeprazole sodium delayed release tablets 4

Figure 5 - rabeprazole sodium delayed release tablets 5

Figure 5 - rabeprazole sodium delayed release tablets 5

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.